Proposal summaries
B2380 - Metabolic effects of statin therapy longitudinal and genetic evidence - 22/01/2015
Aims: Statins are first-line therapy for cardiovascular prevention, yet the effects of statins on lipoprotein subclasses and circulating fatty acids remain unclear. Statin usage may further influence other pathways beyond lipid lowering. We aim to assess the detailed metabolic effects of starting statin therapy by quantitative NMR metabolomics profiling in 4 longitudinal cohort studies with 2 20 years of follow-up (including ALSPAC mothers).
Hypotheses: Starting statin usage is associated of all LDL lipids to a similar extend, but deviating patterns may be observed for detailed VLDL subclasses and their cholesterol and triglyceride levels. We hypothesize that statin lower all fatty acid concentrations, but more so for omega-6 fatty acids than for omega-3 and mono-unsaturated fatty acids. Finally, we will assess the effects of statins on numerous small molecules (including amino acids, glycolysis precursors and ketone bodies) to examine potential non-lipid effects of statins. Longitudinal analyses will be corroborated by genetic analysis, using established genetic instruments to proxy the effect of the statin target: HMGCoA reductase inhibition. Analyses: Associations with starting statin usage with NMR-based metabolite data will be meta-analysed in 4 cohorts including ALSPAC mothers. Genetic associations of 2 SNPs in HMGCR will be tested in 9 population-based cohorts including ALSPAC children & mothers.
Confounding variables: Longitudinal analyses will be adjusted for age and sex. Genetic analyses will be adjusted for age, gender, and population structure if available.
B2379 - Using parents experiences to investigatehow to prevent high risk primary school children developing antisocial and criminal behaviour - 22/01/2015
Aims:
The study aims to investigate what interventions, services or policies could help prevent primary-school
children with conduct problems, living in high risk families, from developing antisocial and criminal
behaviour as they grow older. The study aims to take a broad view as to what could help and has therefore
been designed in two phases. Phase One is a qualitative longitudinal interview study with ten families to
build hypotheses about what might help. I would like to use ALSPAC data in Phase Two of the study. In
Phase Two the aim is to access longitudinal data on larger samples of similarly high need families that
include a child with behaviour problems to explore issues arising from the qualitative interviews. I aim to
explore possible modifiers (referred to as 'modifying factors') of the association between risk factors and
outcomes (antisocial and criminal behaviour in later adolescence). The aim is not to identify pre-existing
protective factors but to look at changes occurring between beginning primary school and adolescence
which appear to indicate a move onto a more positive trajectory. Outcomes will be compared for matched
groups of children who have or have not experienced the modifying factor/exposure. The matching will
be based on risk factors for the ultimate outcomes of interest, i.e.antisocial and criminal behaviour at ages
16+, and it is proposed that propensity score matching be used. This matching will make use of existing
knowledge about factors associated with resilience in an effort to control for these and isolate the impact
of later occurrences (e.g. Bowen, Heron, Steer, & El Comy, 2008). The method is imperfect for looking
at effectiveness of intervention but provides one route to addressing the possibly serious consequences of
prioritising easy-to-research interventions.
B2378 - Do social cognitive deficits at an early age predict substance abuse problems at later ages - 22/01/2015
Aims
The aim of this project is to explore whether early deficits in social cognition are associated with later substance abuse problems. Previous studies have shown that impairments of social cognition are common amongst individuals who abuse substances. For example, alcohol (1), opiate (2), and tobacco (3) use have all been associated with impaired recognition of facial emotional expression. Additionally, these impairments persist when smokers become abstinent (4) and when alcoholics are detoxified (5), suggesting addicted individuals' may rely upon substances to aid their social cognitive abilities. Furthermore, these deficits are sustained up to ~2 months into sobriety (6). This raises the question of whether it is substance abuse itself that cause these deficits, or whether these deficits lead to substance use (for example, to enhance certain aspects of social cognition).
B2377 - Clarifying the SES-Health Gradient The Case for an Epigenetic Mechanism - 15/01/2015
Socioeconomic status (SES), an individual's position in society, is defined by a number of interrelated individual, structural, and environmental factors (e.g., income, education, neighborhood). We have known for some time that an SES-health gradient exists (i.e., low SES associated with poor health, high SES associated with good health) but exactly what it is about SES that gets into the body to shape health is still unclear. Yet, understanding these biological mechanisms will be critical for minimizing the costs of low SES for health as well as maximizing the benefits of high SES for health. This lack of clarity may reflect variations in the measurement of SES, a lack of recognition of factors that influence for whom the SES-health gradient will hold and, until recently, limited availability of epigenetic data. We contend that in order to clarify how SES might get into the body to influence health we should first, determine which indictor(s) of SES, and in which combinations, might work to influence biological mechanisms and second, we should consider whether there might be specific factors that influence for whom SES might get into the body to influence mental and physical health. We believe that psychological well-being is an excellent candidate. The key biological mechanism that we will focus on in these relationships is DNA methylation.
B2376 - Child PTSD and longitudinal adverse outcomes - 15/01/2015
The aim of the proposed study is to provide information regarding potential adverse outcomes associated with trauma exposure and posttraumatic stress symptoms (PTSS). Existing data suggest that youth trauma exposure and/or PTSS are associated with adverse outcomes in several domains including: substantially increased odds of objective physical disease states (Seng et al, 2004); poorer educational attainment (Hurt et al, 2000); engagement in substance use and other risky behaviours (Begle et al, 2011); and increased likelihood of antisocial behaviours/involvement in the youth juvenile justice system (Ford et al, 2010; Abram et al, 2004). However, existing studies are predominantly cross-sectional raising issues of cause versus consequence; or they have focused on specific populations or types of trauma, limiting the generalisability of the findings. The longitudinal data afforded by the ALSPAC cohort would allow for an analysis of whether youth trauma and PTSS contribute to later adverse outcomes, even once concurrent problem levels are taken account of.
B2375 - Genetic and environmental risk factors for the development and maintenance of PTSD with the ALSPAC cohort - 15/01/2015
B2373 - Dietary zinc intake in the ALSPAC cohortan investigation of dietary sources and growth outcomes - 08/01/2015
Aims and hypothesis
Preliminary investigations have shown that average dietary zinc intakes in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort are below those recommended for children and this could be associated with deficits in long-term growth.
Exposure variables
The project will use the dietary data collected longitudinally from ALSPAC children from which nutrient intakes have been calculated. This will be combined with weight and height data collected at several time points throughout childhood. The project will investigate which foods and food groups contribute to zinc intakes in children age 1.5-13 years and whether this has an effect of height and body mass index at several time points throughout childhood.
B2372 - Intake of free sugars in the ALSPAC cohort an investigation of dietary sources and obesity outcomes - 08/01/2015
Aim and hypothesis:
Preliminary investigations have shown that free sugars intakes in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort are above those recommended as a maximum for children and may be associated with fast early growth and obesity outcomes.
B2371 - Patterns predictors and neurobehavioral consequences of multiple metal exposure in pregnancy - 08/01/2015
Aims
Up to 25% of the global burden of disease is estimated to stem from preventable environmental exposures. Starting in utero, millions of children worldwide are exposed to toxic chemicals, including the metals lead, cadmium, and mercury, from natural and anthropogenic sources. Research clearly demonstrates that individually these toxic metals contribute to neurobehavioral deficits in children. It is also accepted that simultaneous exposure to multiple metals is the norm rather than an anomaly. Yet, surprisingly little is known about the combined effects of early exposure to multiple metals on child development and behaviour. Important research gaps, hinder our ability to set policies, create prevention or intervention measures, and care for affected individuals. First, except for select or specific population groups, the exposure to metals in the general population is likely to be of low magnitude. The patterns of exposure in the general population need to be established. Second, it is important to understand what sociodemographic factors are likely to predict exposures so that risk factors can be appropriately described and communicated. Most importantly, there is little understanding of the extent to which metals interact to produce deficits. Thus, the consequences, both in the short and the long-term, of multiple metal exposures need to be determined. The aim of this study is to 1) model the patterns of in utero exposure to three toxic metals (lead, cadmium and mercury), 2) compare sociodemographic factors/variables among groups of women with lowest and highest exposure patterns to identify salient predictors of exposure, and 3) examine the neurobehavioural consequences of exposure for the women's offspring using measures of early temperament and neurocognitive development.
Hypotheses
The central hypothesis is that women falling into the highest metal exposure pattern will have children with more difficult temperaments and lower developmental scores than women falling into the lowest exposure pattern.
B2370 - A multi-omics investigation into the metabolic and epigenetic effects of childhood glycemic profile - 08/01/2015
This study will employ a systematic approach to investigate the effects of childhood glycemic profile on the metabolome and the methylome. We propose that blood glucose level is linked to changes in the metabolome, which results in variation in DNA methylation between individuals. Using Mendelian randomization techniques it will possible to investigate the directionality of this relationship. It is possible that there is a causal relationship between blood glucose level as an environmental exposure due to diet and altered DNA methylation which may alter gene expression.
This systematic approach requires several steps. Firstly, using existing GWAS results, a genetic proxy for blood glucose levels will be used to perform a Mendelian randomisation analysis investigating the effect of blood glucose on the metabolome treating blood glucose as an exposure and metabolome as an outcome. GWAS results will then be used again to find a genetic proxy for the observed metabolome effects, thus obtaining a filtered list of SNPs that can be used in a second MR step to identify differentially methylated CpGs that are associated with changes in the metabolome. It would then be possible to investigate the transcriptional effects of these modifications, linking exposures to molecular mediators and phenotypic outcomes.
This systematic method has is advantageous over traditional EWAS due to the stepwise filtering of SNPs associated with the exposure of interest, and may be more likely to provide biologically interesting data relating to disease phenotypes. ALSPAC provides an ideal opportunity to test the utility of this approach, due to the availability of genotype, NMR metabolomics, DNA methylation and some transcriptional data from a large cohort.
B2369 - Nutrition DNA methylation and child conduct problems - 08/01/2015
Conduct problems (CP) in youth affect society in a wide and penetrating manner; the victimization and distress to individuals and impairment of life opportunities is substantial. The associated costs are thought to be especially severe for youth with an early onset (at or before the age of 10 years) of CP - these youth are often raised in high-risk environments (family, community); show abnormal neurocognitive development; and are at risk for a persistent pattern of offending (1-3).
Previous studies highlight that a poor diet (e.g., consumption of energy-dense foods that are high in saturated fat and low in unsaturated fat) in early life (i.e., in prenatal and early postnatal periods) can disturb child neurodevelopment and lead to cognitive, emotional and behavioural problems in later life (4-13). To date, however, no existing research has integrated - in a developmental context - nutrition (i.e., quantity and quality of dietary fat) and biological markers (genetic, epigenetic and metabolic) that can help to identify the mechanisms underlying the associations between poor nutrition from prenatal period through childhood and CP. For example, although epigenetic modifications have been associated with poor nutrition in general (14), further research is needed to examining the this is related to early onset of CP - and also the degree to which functional variation within genes that are involved in metabolism of the key macronutrients might moderate the associations between nutrition and DNA methylation in relation to CP (15, 16).
This application proposes a systematic examination of the impact of prenatal and postnatal nutrition and environmental risk exposure on CP in The Avon Longitudinal Study of Parents and Children (ALSPAC; UK). The developmental phenotype of CP trajectories between ages 4 and 13 years is available for the ALSPAC children (2). The sub-sample of ALSPAC children includes extensive measures of diet macronutrients using Food Frequency Questionnaire and dietary diary, and nutrition biomarkers available from a prenatal period through late-childhood; as well as whole-genome data for mothers and children; and DNA methylation status data available for children at birth, at ages 7 and 15-17 years.
The project aims to address the following research questions:
Aim 1: Does prenatal and/or early postnatal nutrition affect CP developmental trajectories?
Sub Aim 1a: Are these associations mediated by earlier neuro-cognitive development?
Sub Aim 1b: Are these associations affected by child stress exposures?
Aim 2: Are associations between nutrition and CP (partially) explained by DNA methylation?
Sub Aim 2: Are these associations moderated by child stress exposures?
Aim 3: Examine the role of SNPs involved in the metabolic pathways of key nutrients.
Aim 4: Examine causal associations using Mendelian Epigenetic Randomization.
B2368 - Genetic overlap between autoimmune diseases and allergic sensitization - 08/01/2015
This project will require no further data form ALSPAC. Data were provided as summary statistics for a meta-GWAS of allergic sensitization (Bonnelykke et al. Nat Gen 2013; 45(8):902-6) based on ALSPAC skin prick tests. The current proposal is to look up reported genes for other immune diseases in the meta-GWAS results, not limited to genome-wide significant loci, to study to which extent these are also associated with allergic sensitization
B2367 - Investigating the prevalence and predictors of e-cigarette use - 08/01/2015
Aims and hypotheses
Electronic-cigarettes (e-cigarettes) hold the potential to hugely reduce the harm caused by smoking, but it is important to determine the factors which lead to their use among young people. Previous cross-sectional research has investigated the prevalence of e-cigarette use among young people (1, 2), but to our knowledge, there have been no longitudinal studies investigating predictors of e-cigarette use.
ALSPAC has collected detailed information about substance use, in particular smoking behaviour. From these data, trajectories of smoking initiation during adolescence have been constructed (3). However, there is currently limited information regarding e-cigarette use. Identifying the pathways into e-cigarette use among young adults is key, given concerns regarding the potential of e-cigarettes to act as a 'gateway' to other, more harmful substances, such as conventional tobacco cigarettes (4). The ALSPAC young people are now between 22 and 23 years old. Therefore, this application is timely as data suggest that peak prevalence of e-cigarette use is in 16-24 and 25-34 year olds (5).
In this project, we aim to collect detailed information from the young people in ALSPAC regarding use of e-cigarettes; specifically frequency of use, demographics of users and dual use with tobacco cigarettes. Using this information, along with the rich data set already available within ALSPAC, we aim to answer the following questions:
1. What biological, social and environmental factors are associated with e-cigarette use in young people?
2. Are e-cigarettes likely to act as a 'gateway' to use of other, more harmful drugs among young people?
3. Is e-cigarette use an effective smoking cessation strategy among young people?
Study design
We will design questions on e-cigarette use to be included in the next annual questionnaire (2015/16) that will be sent to the ALSPAC young people. These data will be linked to previous ALSPAC data, allowing investigation of the biological, social and environmental factors associated with e-cigarette use. We are seeking funding for the data collection from Cancer Research UK (CRUK) have been asked to submit a full application by 22nd January 2015.
We will seek additional funding in the future to send follow up questionnaires, which will allow us to examine the long term implications of e-cigarette use. We would also like to extend this work to investigate e-cigarette use in the ALSPAC mothers and fathers.
B2366 - Exploring the relationship between antibiotic exposure in early life and psychological problems in preschool years - 08/01/2015
Research Question:
Are infants born to the ALSPAC cohort who received one or more courses of antibiotics during the fetal and early life more likely to develop psychological problems during their preschool years when compared to children who were not exposed to antibiotics?
Hypothesis:
It is hypothesized that antibiotic exposure during fatal and early life will disrupt the natural development of the human microbiome during a critical window of vulnerability. This will result in behavioural changes which will be observed as a higher prevalence of psychological problems in preschool years.
B2365 - Rare copy number variants and education achievement - 08/01/2015
Aims and hypothesis
The impact of rare copy number variants (CNVs) has almost exclusively been evaluated using clinical cohorts; it is thus unclear how these variants affect health in the general population. Our aim is to assess the genome-wide burden of rare CNVs on carriers' health and life quality in general population. We have conducted genotype and phenotype analyses of a random sample of 7877 adult individuals from the population biobank of Estonia (Estonian Genome Center, University of Tartu; Tartu, Estonia). Using this set we generated a genome-wide map of rare autosomal CNVs and identified 10.5% of the screened adult general population (n=831) as carriers of CNVs >=250kb with frequency <=0.05%. We found that when compared to the population, carriers of deletions >=250kb and duplications >=1Mb show lower education achievements (a proxy for intelligence) and a greater prevalence of intellectual disability. These effects are associated with the number and functions of contained genes, e.g. rare deletions are significantly enriched for genes with a role in neurogenesis, cognition, learning, memory and behavior. Interestingly, the effect on education attainment was more pronounced in female carriers of rare deletions in general population, who were also overrepresented amongst carriers.
Our results suggesting that rare CNVs contribute to a substantial portion of the population variance of educational attainment need to be replicated in a geographically independent cohort. The ALSPAC cohort of mothers and children would provide us, in collaboration with group of Dr. Nicholas Timpson, a valuable result as (i) ethnically unrelated to the discovery cohort; (ii) sufficient sample size of individuals with CNVs calls; (iii) the cognitive information of children is unbiased by preselection; (iii) large number of uniformly recruited females provides a possibility to validate the female effect of rare CNVs.
B2364 - Genetics and genomics of polycystic ovary syndrome and related sub-phenotypes - 08/01/2015
Polycystic ovary syndrome (PCOS) is a complex disorder causing metabolic disturbances and reduced fertility in women of reproductive age, the definition of which is an on-going debate among researchers in the field. PCOS is characterized by hyperandrogenism, chronic anovulation and glucose homeostasis. It is one of the most common endocrinopathies affecting 5-15% of women of reproductive age worldwide and causes more than 75% of cases of anovulatory infertility. The etiology of PCOS is largely unknown though contains a clear genetic component. However, to date, the only available PCOS genome-wide association data have reported 11 significant loci and come from a study of Han Chinese individuals. We, in the PCOS consortia, that consists of 15+ research teams, are gearing up to perform their first and second waves of genome-wide and also exome-wide association meta-analyses in up to 15,000 cases and 80,000 controls of European decent, as well as extensive pathway analysis and genomic follow-up. The overall aim is to identify genetic variation, transcripts and pathways that are associated with PCOS susceptibility (and related subphenotypes). We will perform case:control analysis for PCOS itself and for some of the related subphenotypes which present as dichotomous outcomes. We will in parallel perform quantitative analysis for subphenotypes that are quantitative traits. We will adjust for standard confounders like age and also investigate what effect related phenotypes like BMI have on the PCOS results by performing both adjusted and unadjusted analysis. The genetic and genomic discovery paired with biologic follow-up, holds the promise of bridging and linking knowledge from the metabolic and gynecologic disease fields and yield clinically useful information.
B2363 - Meta-analysis of the association of gestational weight gain with offspring outcomes - 08/01/2015
Background
Maternal early- / pre-pregnancy BMI and gestational weight gain have been shown to be positively associated with offspring greater adiposity in later life in numerous prospective cohort studies, including in previous publications from ALSPAC. However, the extent to which this association is causal or due to bias (including publication bias, where studies that show a positive association are more likely to be published) is unclear.
We want to explore this by undertaking an individual participant meta-analysis in all birth cohorts (globally) that we can identify and that have relevant data. Our aim is that this should allow us to obtain precise estimates that are less likely to be influenced by publication bias than undertaking a systematic reivew and meta-analysis of published studies.
Further we want to compare association of maternal exposures with offspring outcomes to the same associations in fathers in order to determine whether there is evidence of specific maternal associations, which would support a intrauterine causal effect.
Aims and objectives
1. To undertake an independent participant data meta-analysis of the association of maternal pre-pregnancy BMI and gestational weight gain with offspring adiposity and body composition.
2. To compare associations of maternal exposures with offspring outcomes to the same associations of paternal exposures to explore whether associations in mothers are likely to represent intrauterine causal mechanisms
3. To explore the extent to which any associations might be mediated by birth characterists and later offspring activity and energy intake
B2361 - Assessing the extent to which disclosurecontrol techniques impact on data utility - 18/12/2014
Cohort studies are required to comply with stringent ethico-legal safeguards when using individual level personal data; particularly when these data relate to sensitive topics. Many of the CLOSER cohort studies make assurances to study participants that participant identity will be known to core study staff, but hidden to the research end users of the data. Cohort data managers use a variety of processes to 'hide' participant identities, ranging from removing name and address information from data sets to complex statistical processes used to mask or block access to the underlying individual level data. In addition to any reassurances made to participants, cohort studies are required to comply with a range of legislation relating to participant confidentiality. The Data Protection Act 1998 makes a distinction between personal data and anonymous data; where personal data is information that relates to an identifiable individual.
This includes data which includes direct identifiers or where identity can be determined through linking to other readily available information. This classification is important as the safeguards required for the use of personal information are far more stringent than the safeguards required for the use of anonymous information. The Data Protection Act 1998 requires that individuals are informed of the use of their personal information, and in the case of sensitive personal information (such as information relating to health or criminality status) that consent is obtained. Furthermore, even when these safeguards are in place the Act requires that data are de-identified as soon in the research process as possible - ideally prior to point when data are provided to researchers. Achieving anonymity in a dataset is challenging and is complicated by the fact that detailed individual-level data is relatively easy to associate back to the individual who provided them.
In 2013 the Health and Social Care Information Centre (HSCIC) released the Anonymisation Standard for the Release of Health and Social Care Data . The HSCIC's chosen methodologies are seen as consistent with the Information Commissioner's Office (ICO) Anonymisation Code of Practice. The ICO have subsequently endorsed the standards anonymisation protocol. In this context, 'release' is taken to mean the distribution of cohort information from the central collecting organisation (e.g. ALSPAC) to research end users. The Anonymisation Standard adopted a statistical process known as K-anonymisation to control for disclosure risk through the suppression of unique patterns within individual-level data. The process works by transforming individual-level values to ensure that each individual record has k other records with identical values. Through suppressing uniqueness, K anonymisation reduces the potential for deductive disclosure. A concern, however is that the loss of information inevitably involved in this process (the scale of which increases as the K threshold is raised) may lead to a reduction in the epidemiological utility of the data.
This question can be addressed empirically. In ALSPAC we have linked study data to a number of
sources of health and social administrative data including the Hospital Episodes Statistics database.
Where linkage to HES is not undertaken within explicit individual consent but is permitted under
provision of Section 251 of the NHS Act 2006 different stipulations apply depending on the sensitivity of the data items linked. Information related to Sexual Health and Mental Health, for example is considered to be particularly sensitive and in this situation stipulations around "stronger" K anonymisation are likely to apply. Around 40% of our participants have explicitly consented to data linkage therefore considerations around K-anonymisation do not apply in the same way. We are therefore able to examine the influence, if any of different levels of k-anonymisation (and other privacy protection procedures) on effect estimates derived from a particular dataset. To do this we will apply a series of different anonymisation processes to a data set used in an existing, published, ALSPAC project on prevalence and risk factors for self-harm. Through undertaking equivalent analyses in the same dataset subject to different levels of disclosure control we will investigate the effect of the following common strategies:
1) no disclosure control beyond removing direct identifiers, 2) controlling for low cell counts in each
individual variable in isolation, 3) applying 'weak' k-anonymisation (at different k thresholds) to all
pseudo-identifiers in the data set in combination, 4) applying 'strong' k-anonymisation (at different k
thresholds) to all variables in the data set bar the outcome variable, 5) applying an alternative approach to anonymisation, which perturbs the data through adding a known level of 'noise' in order to mask ALSPAC Research Proposal Form page 8 of 10 December 2010the true underlying values, and, 6) using single-site DataSHIELD as a means of restricting access to the underlying individual-level data. Option 5 will render the data to a state where it is not real in any sense (i.e. the variable values will not relate to any individual as they have been statistically altered).
We will provide the research analyst with sufficient information to remove the noise from the data in their modelling (akin to the modelling undertaken to control for measurement error problems). As the artificial noise data is known, it will be possible to remove the effect of the transformations through the modelling and therefore allow the analyst to produce accurate results without ever being aware of the true underlying individual level data that relates to a study participant. In contrast, Option 6, will not attempt to alter the values of the underlying data. Instead, DataSHIELD will operate as a protective IT framework which will allow the analyst a means of extracting statistical information without having access to the underlying individual level data. This process is consistent with the principles of the ICOs anonymisation code of practice.
We will repeat this assessment, in a different exemplar setting, using self-reported information recording breast feeding and IQ, and linked educational assessment information from the National Pupil Database. The exposure variables, outcome variables and confounder variables are all pre-determined by the choices of the original investigators. This project is not designed as an investigation of these exemplar topics
B2360 - Aetiology of increased birthweight for gestation - 18/12/2014
Background: There is increasing evidence that childhood cancer is more likely to occur in children that were relatively large at birth, and unpublished information indicates that this is particularly true of non-leukaemic cancers occurring after 3 years of age [1]. The risk is lowest among children born small-for-dates and tends to increase linearly with increasing birth-weight. The evidence indicates that the birth-weight association with leukaemia relates to excessive growth in utero [2,3]. This raises the question as to whether there are features that increase the growth of the fetus that are responsible for increases in the risk of cancer. Although many high quality studies have focused on the aetiology of growth retardation, little attention has been paid to the high end of the birth-weight distribution.
Hypothesis and objectives: This study is designed to identify factors that influence fetal growth in order to develop coherent hypotheses as to ways in which the unexplained link with childhood cancer may be explained. We hypothesise that features of the environment including diet and lifestyle, genetics and epigenetics may play important parts. We have already shown an excess in birth-weight if the non-smoking mother was exposed in utero to her own grandmother's smoke [4], which indicates a possible epigenetic influence; additionally our unpublished data have shown an association with maternal prenatal intake of paracetamol (acetaminophen). Thus our hypotheses concern the likely complexity of factors that influence excessive fetal growth.
The objectives are to determine features of the life-course of each parent, and grandparent, to determine associations with increased fetal growth using an 'exposome' approach [as in B2190]. Where appropriate, linkage to genetic variants and methylation patterns will be used to determine biological pathways which may be associated with childhood cancer.
B2358 - Study of Emerging Adulthood and Cardiometabolic Health in ALSPAC the iNfluence of Growth and other Exposures-SEACHANGE - 18/12/2014
Hypothisis
1. Changes in exposures over the period 17-25y will be associated with change in cardiometabolic
phenotype over the period 17-25y.
2. These associations will be reflected in changes in intermediate molecular phenotypes (epigenetics and
metabolomic measures).
3. Changes in intermediate molecular phenotypes will act as markers of exposure, and, in some cases,
highlight possible causal pathways
4. Exposures over the entire life course to 25y will act via accumulative or sensitive period models to
determine outcomes at age 25y
Outline of the proposed study
ALSPAC commenced in 1990-92 and recruited children from 15 247 pregnancies.73 Follow-up data includes 59 questionnaires (4 weeks-18 years of age) and 9 clinical assessment visits (7-17 years of age). The resource comprises a wide range of phenotypic and environmental measures in addition to biological samples, genetic (DNA on 11,343 children, genome-wide data on 8,365 children, complete genome sequencing on 2000 children) and epigenetic (methylation sampling on 1000 children) information and linkage to health and administrative records.
Young adults participating in the ALSPAC study will be invited to re-attend clinic for detailed assessment of exposures, risk factors and phenotype. Based on previous experience and pilot studies, we anticipate approximately 4000-5000 young adults will attend the 25+ clinic. We will undertake a range of investigations including: cardiac structure and function by 3-dimensional (3D) echocardiography, including strain rate using a EPIQ 7 ultrasound (3D echo offers significant advantages over 2D/M-mode in the assessment of LV mass and remodelling[74]); carotid ultrasound for cIMT and carotid distensibility will be performed using a Panasonic CardioHealth station; carotid-femoral PWV will be measured using a Vicorder device; peripheral and central BP including waveform analysis (pressure separation75, reservoir/excess pressure) will be measured using a BP+ validated cuff-based device. BP and HR reactivity in response to a step exercise and handgrip will also be performed as done in ALSPAC 17+ clinic. Resting heart rate variability will be measured from a 5 minute resting ECG. Anthropometry, questionnaires (including dietary questionnaires), fasting bloods, urine, 3D body scans, metabolomics and DXA will be performed as part of the core clinic (supported by existing core-grant). Blood samples will also be collected for analysis of insulin (all participants), DNA methylation (in 1000 participants), chromatin preparation and storage. Urine will also be collected and stored.